Medically accurate genetic test results—no more “guestimate” recommendations.
Convenience of telemedicine provides access to patients who may have difficulty seeing a cannabis specialist in person.
Certainty of treatment by medical professionals who are specifically trained in cannabis medicine by the world’s leading scientific and medical authorities.
Cost-effective treatment options that are often covered by insurance.
GATC Canna combines best-in-class technologies into one easy to use platform, allowing doctors to enter and excel in the lucrative and under-served medical cannabis market.
Aggressive patient acquisition through GATC Canna’s marketing engine.
HIPAA-compliant telemedicine technology allows doctors to see more patients by eliminating in-person office visits.
Scheduling initial and follow-up consultations is easy for patients, increasing recurring revenue for doctors.
Doctor training from the world’s leading scientists and doctors in the cannabis field.
Recommendations are based on the industry-leading genomic testing, with 99.99% accuracy and world-class artificial intelligence analysis
HOW IT WORKS
There are five main components to GATC Canna’s revolutionary platform.
Who We Are
GATC Canna was borne from the vision that medical diagnoses should be based on the most accurate scientific data, made available to doctors and patients via a powerful, easy-to-use portal. Our management and advisory teams are comprised of passionate, experienced professionals in the medical, diagnostic, technology and finance fields.
World-class leadership and industry-best technology combine to deliver on the promise of accurate medical cannabis recommendations.
For information regarding investment opportunities with GATC Canna, please contact our Investor Relations department using the email below.
Contact GATC Canna
4540 Campus Drive, Suite 100, Newport Beach, CA 92660, USA